A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis 01

Stopped early · Phase 3 · Has a placebo group

Conditions studied: Gastroparesis, Diabetes Mellitus

In brief

This study will evaluate the safety and efficacy of relamorelin compared to placebo in participants with diabetic gastroparesis. Participants will report daily severity scores of their diabetic gastroparesis symptoms.

Key facts

Study ID
NCT03285308
Run by
Allergan
People needed
336
Starts
2017-09-29
Expected to finish
2020-07-08
Last updated by the study team
2021-07-29

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.